Wynnefield Partners Small Cap Value, L.P. 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-07 4:25 pm Purchase | 2023-01-09 | 13D | LIFECORE BIOMEDICAL INC LFCR | Wynnefield Partners Small Cap Value, L.P. | 5,387,830 17.900% | 461,035 (+9.36%) | Filing |
| 2023-01-12 5:13 pm Purchase | 2023-01-09 | 13D | LIFECORE BIOMEDICAL INC LFCR | Wynnefield Partners Small Cap Value, L.P. | 4,926,795 16.600% | 2,362,271 (+92.11%) | Filing |